US Preventive Services Task Force recommends primary cervical HPV testing as an effective cervical cancer screening method

US Preventive Services Task Force recommends primary cervical HPV testing as an effective cervical cancer screening method

Cervical cancer is the fourth most common cancer in women worldwide. In the US, deaths from cervical cancer have decreased by more than 50 percent over the past 60 years, since the introduction of regular screening tests that detect high-grade precancerous cervical lesions and cervical cancer. However, over 13,000 women are diagnosed with cervical cancer annually and about 4,200 women die from it, even with screening and treatment. Recommendations continue to evolve, reflecting the latest screening technology and evidence. The new USPSTF recommendations for screening have been recently published in the latest issue of JAMA. Women over 30 now have three options for screening, including HPV testing alone; the other two options are pap smear and a combination of pap smear and HPV testing. HPV testing has been shown to be more effective than a pap test as it is able to detect precancerous cells earlier and more accurately than cytology. These screening guidelines update the previous guidelines; now, for...
Read More
12